- Home
- LFMD vs CADL Comparison
LFMD vs CADL Comparison
Compare LFMD & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LFMD
- CADL
- Stock Information
- Founded
- LFMD 1994
- CADL 1999
- Country
- LFMD United States
- CADL United States
- Employees
- LFMD N/A
- CADL N/A
- Industry
- LFMD Medical/Nursing Services
- CADL Biotechnology: Pharmaceutical Preparations
- Sector
- LFMD Health Care
- CADL Health Care
- Exchange
- LFMD Nasdaq
- CADL Nasdaq
- Market Cap
- LFMD 306.7M
- CADL 306.4M
- IPO Year
- LFMD N/A
- CADL 2021
- Fundamental
- Price
- LFMD $5.61
- CADL $5.31
- Analyst Decision
- LFMD Strong Buy
- CADL Strong Buy
- Analyst Count
- LFMD 7
- CADL 4
- Target Price
- LFMD $11.57
- CADL $21.00
- AVG Volume (30 Days)
- LFMD 1.5M
- CADL 1.1M
- Earning Date
- LFMD 05-07-2025
- CADL 03-13-2025
- Dividend Yield
- LFMD N/A
- CADL N/A
- EPS Growth
- LFMD N/A
- CADL N/A
- EPS
- LFMD N/A
- CADL N/A
- Revenue
- LFMD $212,453,838.00
- CADL N/A
- Revenue This Year
- LFMD $29.08
- CADL N/A
- Revenue Next Year
- LFMD $18.81
- CADL N/A
- P/E Ratio
- LFMD N/A
- CADL N/A
- Revenue Growth
- LFMD 39.27
- CADL N/A
- 52 Week Low
- LFMD $3.99
- CADL $1.56
- 52 Week High
- LFMD $12.88
- CADL $14.60
- Technical
- Relative Strength Index (RSI)
- LFMD 49.54
- CADL 28.78
- Support Level
- LFMD $5.14
- CADL $7.85
- Resistance Level
- LFMD $6.15
- CADL $5.90
- Average True Range (ATR)
- LFMD 0.36
- CADL 0.63
- MACD
- LFMD -0.00
- CADL -0.35
- Stochastic Oscillator
- LFMD 46.53
- CADL 4.80
About LFMD LifeMD Inc.
LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment.
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.